Peter Marks (Greg Nash/Pool via AP Images)

FDA con­venes com­mit­tee of vac­cine ex­perts to con­sid­er a flu-like path for Omi­cron-spe­cif­ic boost­ers

Al­though the FDA signed off last week on a sec­ond Covid-19 boost­er shot for those who are over 50 years old, with­out first con­sult­ing its …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.